Classification and Pathology of Lung Cancer.
Advancement in the understanding of lung tumor biology enables continued refinement of lung cancer classification, reflected in the recently introduced 2015 World Health Organization classification of lung cancer. In small biopsy or cytology specimens, special emphasis is placed on separating adenocarcinomas from the other lung cancers to effectively select tumors for targeted molecular testing. In resection specimens, adenocarcinomas are further classified based on architectural pattern to delineate tissue types of prognostic significance. Neuroendocrine tumors are divided into typical carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma based on a combination of features, especially tumor cell proliferation rate.
Department of Pathology, Jersey Shore University Medical Center, 1945 Route 33, Neptune, NJ 07753, USA. Electronic address: mzheng@meridianhealth.com.
Min
M
Zheng
D002276:Carcinoid Tumor / Q000145:classification / Q000473:pathology*; D018278:Carcinoma, Neuroendocrine / Q000145:classification / Q000473:pathology*; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification* / Q000473:pathology*; D018358:Neuroendocrine Tumors / Q000145:classification / Q000473:pathology*; D055752:Small Cell Lung Carcinoma / Q000145:classification / Q000473:pathology*
Classification; Immunohistochemistry; Lung cancer; Molecular testing; Pathology